Susquehanna International Group
PPH icon

Susquehanna International Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Susquehanna International Group’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$603K Sell
5,800
-64,200
-92% -$6.84M ﹤0.01% 9189
2025
Q4 		$7.22M Buy
70,000
+60,300
+622% +$5.87M ﹤0.01% 3490
2025
Q3 		$876K Sell
9,700
-13,600
-58% -$1.19M ﹤0.01% 7660
2025
Q2 		$2.05M Buy
23,300
+10,200
+78% +$884K ﹤0.01% 5723
2025
Q1 		$1.19M Buy
13,100
+800
+7% +$72K ﹤0.01% 6808
2024
Q4 		$1.06M Buy
12,300
+700
+6% +$63.3K ﹤0.01% 6801
2024
Q3 		$1.1M Buy
11,600
+2,400
+26% +$228K ﹤0.01% 6565
2024
Q2 		$842K Sell
9,200
-7,400
-45% -$661K ﹤0.01% 6994
2024
Q1 		$1.51M Buy
16,600
+2,700
+19% +$236K ﹤0.01% 6002
2023
Q4 		$1.13M Buy
13,900
+7,300
+111% +$572K ﹤0.01% 6689
2023
Q3 		$527K Sell
6,600
-400
-6% -$32.3K ﹤0.01% 8102
2023
Q2 		$551K Buy
7,000
+3,300
+89% +$258K ﹤0.01% 8092
2023
Q1 		$287K Sell
3,700
-38,400
-91% -$2.96M ﹤0.01% 9822
2022
Q4 		$3.27M Sell
42,100
-29,200
-41% -$2.15M ﹤0.01% 3872
2022
Q3 		$4.79M Buy
71,300
+35,500
+99% +$2.62M ﹤0.01% 3222
2022
Q2 		$2.75M Buy
35,800
+31,600
+752% +$2.47M ﹤0.01% 4234
2022
Q1 		$335K Sell
4,200
-600
-13% -$45.9K ﹤0.01% 10003
2021
Q4 		$369K Sell
4,800
-3,300
-41% -$245K ﹤0.01% 9989
2021
Q3 		$589K Buy
8,100
+2,400
+42% +$179K ﹤0.01% 8948
2021
Q2 		$416K Buy
+5,700
New +$406K ﹤0.01% 10030
2021
Q1 		– Sell
-66,100
Closed -$4.39M – 12708
2020
Q4 		$4.39M Buy
+66,100
New +$4.24M ﹤0.01% 3629
2020
Q3 		– Sell
-21,600
Closed -$1.34M – 11012
2020
Q2 		$1.34M Sell
21,600
-21,500
-50% -$1.3M ﹤0.01% 5254
2020
Q1 		$2.34M Buy
43,100
+2,500
+6% +$154K ﹤0.01% 3694
2019
Q4 		$2.61M Buy
40,600
+26,200
+182% +$1.58M ﹤0.01% 3909
2019
Q3 		$819K Sell
14,400
-9,800
-40% -$561K ﹤0.01% 6140
2019
Q2 		$1.42M Buy
24,200
+13,100
+118% +$758K ﹤0.01% 4895
2019
Q1 		$674K Buy
11,100
+2,100
+23% +$124K ﹤0.01% 5736
2018
Q4 		$496K Buy
+9,000
New +$545K ﹤0.01% 6048
2018
Q2 		– Sell
-7,200
Closed -$408K – 10216
2018
Q1 		$408K Buy
+7,200
New +$430K ﹤0.01% 7040
2017
Q4 		– Sell
-5,400
Closed -$312K – 9764
2017
Q3 		$312K Buy
+5,400
New +$307K ﹤0.01% 7318
2016
Q4 		– Sell
-7,300
Closed -$419K – 10016
2016
Q3 		$419K Buy
+7,300
New +$438K ﹤0.01% 6387
2016
Q1 		– Sell
-4,000
Closed -$261K – 9513
2015
Q4 		$261K Sell
4,000
-7,700
-66% -$497K ﹤0.01% 7954
2015
Q3 		$737K Buy
+11,700
New +$822K ﹤0.01% 6347

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Susquehanna International Group's PPH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Pharmaceutical ETF (PPH) stake by 1,204% in Q1 2026, buying an estimated $8.28M and bringing the position to 84,211 shares worth $8.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Susquehanna International Group first reported a position in PPH in Q3 2013 and has held it in 40 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Susquehanna International Group held 84,211 shares of VanEck Pharmaceutical ETF worth $8.75M as of Q1 2026.
  • Susquehanna International Group bought 77,754 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $8.28M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3316 holding.
  • Susquehanna International Group first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 40 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.